BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9714354)

  • 1. Cytokines and adhesion molecules in patients with polymyalgia rheumatica.
    Uddhammar A; Sundqvist KG; Ellis B; Rantapää-Dahlqvist S
    Br J Rheumatol; 1998 Jul; 37(7):766-9. PubMed ID: 9714354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In polymyalgia rheumatica serum prolactin is positively correlated with the number of typical symptoms but not with typical inflammatory markers.
    Straub RH; Georgi J; Helmke K; Vaith P; Lang B
    Rheumatology (Oxford); 2002 Apr; 41(4):423-9. PubMed ID: 11961173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian variations in clinical symptoms and concentrations of inflammatory cytokines, melatonin, and cortisol in polymyalgia rheumatica before and during prednisolone treatment: a controlled, observational, clinical experimental study.
    Galbo H; Kall L
    Arthritis Res Ther; 2016 Jul; 18(1):174. PubMed ID: 27455959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the regulation of levels of plasma adhesion molecules by proinflammatory cytokines and their soluble receptors in type 1 diabetes.
    Mohamed-Ali V; Armstrong L; Clarke D; Bolton CH; Pinkney JH
    J Intern Med; 2001 Nov; 250(5):415-21. PubMed ID: 11887976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
    Salvarani C; Boiardi L; Macchioni P; Rossi F; Tartoni P; Casadei Maldini M; Mancini R; Beltrandi E; Portioli I
    Ann Rheum Dis; 1995 Aug; 54(8):640-4. PubMed ID: 7677440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica.
    Uddhammar A; Rantapåå-Dahlqvist S; Nilsson TK
    Clin Rheumatol; 1992 Jun; 11(2):211-5. PubMed ID: 1617895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum soluble CD4 and CD8 levels in polymyalgia rheumatica.
    Salvarani C; Boiardi L; Macchioni P; Casadei Maldini M; Mancini R; Beltrandi E; Rossi F; Portioli I
    J Rheumatol; 1994 Oct; 21(10):1865-9. PubMed ID: 7837152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical value of measuring soluble interleukin-2 receptor in polymyalgia rheumatica.
    Gripenberg M; Franzén P; Fröseth B
    Scand J Rheumatol; 1995; 24(1):26-8. PubMed ID: 7863274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica.
    Kreiner F; Galbo H
    Scand J Rheumatol; 2010; 39(5):402-8. PubMed ID: 20615159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
    Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin 2 receptors in polymyalgia rheumatica/giant cell arteritis. Clinical and laboratory correlations.
    Salvarani C; Macchioni P; Boiardi L; Rossi F; Casadei Maldini M; Mancini R; Beltrandi E; Spacca C; Lodi L; Portioli I
    J Rheumatol; 1992 Jul; 19(7):1100-6. PubMed ID: 1512765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable role of interleukin 10 in patients with polymyalgia rheumatica.
    Straub RH; Herfarth HH; Rinkes B; Konecna L; Glück T; von Landenberg P; Georgi J; Helmke K; Schölmerich J; Vaith P; Lang B
    J Rheumatol; 1999 Jun; 26(6):1318-25. PubMed ID: 10381050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis.
    Cutolo M; Montecucco CM; Cavagna L; Caporali R; Capellino S; Montagna P; Fazzuoli L; Villaggio B; Seriolo B; Sulli A
    Ann Rheum Dis; 2006 Nov; 65(11):1438-43. PubMed ID: 16644782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis.
    Sulli A; Montecucco CM; Caporali R; Cavagna L; Montagna P; Capellino S; Fazzuoli L; Seriolo B; Alessandro C; Secchi ME; Cutolo M
    Ann N Y Acad Sci; 2006 Jun; 1069():307-14. PubMed ID: 16855158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated soluble intercellular adhesion molecule 1 in the serum of patients with polymyalgia rheumatica: influence of steroid treatment.
    Macchioni P; Boiardi L; Meliconi R; Salvarani C; Grazia Uguccioni M; Rossi F; Pulsatelli L; Facchini A
    J Rheumatol; 1994 Oct; 21(10):1860-4. PubMed ID: 7837151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CRP initial response to treatment as prognostic factor in patients with polymyalgia rheumatica.
    Schreiber S; Buyse M
    Clin Rheumatol; 1995 May; 14(3):315-8. PubMed ID: 7641508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute-phase reactants and the risk of relapse/recurrence in polymyalgia rheumatica: a prospective followup study.
    Salvarani C; Cantini F; Niccoli L; Macchioni P; Consonni D; Bajocchi G; Vinceti M; Catanoso MG; Pulsatelli L; Meliconi R; Boiardi L
    Arthritis Rheum; 2005 Feb; 53(1):33-8. PubMed ID: 15696567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of tumor necrosis factor-alpha, soluble intercellular adhesion molecule-1, soluble vascular cell adhesion molecule-1, and soluble interleukin-1 receptor antagonist in patients with thyroid eye disease undergoing treatment with somatostatin analogues.
    Krassas GE; Pontikides N; Doukidis D; Heufelder G; Heufelder AE
    Thyroid; 2001 Dec; 11(12):1115-22. PubMed ID: 12186498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha 1-antichymotrypsin, C-reactive protein and erythrocyte sedimentation rate in polymyalgia rheumatica and giant cell arteritis.
    Pountain GD; Calvin J; Hazleman BL
    Br J Rheumatol; 1994 Jun; 33(6):550-4. PubMed ID: 8205403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6.
    Cutolo M; Straub RH; Foppiani L; Prete C; Pulsatelli L; Sulli A; Boiardi L; Macchioni P; Giusti M; Pizzorni C; Seriolo B; Salvarani C
    J Rheumatol; 2002 Apr; 29(4):748-56. PubMed ID: 11950017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.